Cases & Deals

  • Home
  • Practices
  • Asia-based USD fund leads seed series investment in life sciences start-up based in California developing novel disease-associated targets discovered using proteogenomic approach

Share

Asia-based USD fund leads seed series investment in life sciences start-up based in California developing novel disease-associated targets discovered using proteogenomic approach

March 2026

Client(s) Asia-based USD fund

Jones Day advised an Asia-based USD fund in its lead seed series investment in a life sciences start-up based in California that is developing novel disease-associated targets discovered using a proteogenomic approach.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.